[1] LI YY, DONG RJ, SHRESTH AS, et al.AIDS-associated Talaromycesmarn effeicentral nervous system infection in patients of southwestern China[J]. AIDS Res Ther, 2020, 17(1):26. [2] LE T, CHI NH, CUC NT, et al.AIDS-Associated Penicillium marneffei Infection of the Central Nervous System. Clin Infect Dis, 2010, 51(12):1458-1462. [3] 卢焕, 黎彦君, 秦英梅, 等. 艾滋病合并中枢神经系统马尔尼菲篮状菌病临床特征[J]. 中国感染控制杂志, 2023, 22(6):674-679. [4] 中华医学会感染病学分会艾滋病学组,中国疾病预防控制中心. 中国艾滋病诊疗指南(2018版)[J/CD]. 新发传染病电子杂志, 2019, 4(2))65-84. [5] ANDRIANOPOULOS A.Control of morphogenesis in the human fungal pathogen penicillium marneffei[J]. Int J Med Microbiol, 2002, 292(5-6):331-347. [6] KAWILA R, CHAIWARITH R, SUPPARATPINYO K.Clinical and laboratory characteristics of penicilliosis marnefei among patients with and without HIV infection in Northern Thailand: a retrospective study[J]. BMC Infect Dis, 2013, 13:464. [7] JIANG J, MENG S, HUANG S, et al.Effects of Talaromyces marneffei infection on mortality of HIV/AIDS patients in southern China: a retrospective cohort study[J]. Clin Microbiol Infe, 2019, 25(2): 233-241. [8] 中华医学会感染病学分会艾滋病丙型肝炎学组. 艾滋病合并马尔尼菲篮状菌病诊疗专家共识(2024年更新版)[J]. 中国艾滋病性病, 2024, 30(6):563-572. [9] LI X, WANG J, HE J, ZHANG H, et al.Talaromyces marneffei central nervous system infection unveiled by the novel Mp1p antigen detection assay in AIDS patient[J]. BMC Infect Dis, 2024, 24(1):1456. [10] GU W, MILLER S, CHIU CY.Clinical metagenomic next-generation sequencing for pathogen detection. Annu Rev Pathol, 2019, 14:319-338. [11] 汪燕岱久, 高丽, 张米, 等. 艾滋病AIDS合并马尔尼菲篮状菌感染临床检测方法研究进展[J]. 中国真菌学杂志, 2024, 19(3):292-296. [12] 韩静, 蒋忠胜, 王刚, 等. 广西人类免疫缺陷病毒感染者/AIDS患者合并马尔尼菲篮状菌感染的特征及Mp1p抗原快速筛检的研究[J]. 微生物与感染, 2021, 16(1):19-25. [13] LI X, WANG J, HE J, ZHANG H, et al.Talaromyces marneffei central nervous system infection unveiled by the novel Mp1p antigen detection assay in AIDS patient[J]. BMC Infect Dis, 2024, 24(1):1456. [14] QIN YY, ZHOU YH, LIU ST, et al.HIV-associated talaromycosis:does timing of antiretroviral therapy matter?[J]. J Infect, 2022, 84(3):410-417. |